121 results
8-K
EX-99.1
ENVB
Enveric Biosciences Inc
18 Sep 23
Enveric Biosciences to Present Poster Highlighting EVM301 Series at the International Conference on Molecular Biology and Biochemistry 2023
8:05am
the mode of engagement with the 5HT2A receptor, which has facilitated the design and synthesis of novel and high-quality drug molecules. Using a robust
8-K
EX-1.1
8ozymy
1 Sep 23
Entry into a Material Definitive Agreement
5:26pm
8-K
icv278otra
23 Sep 22
Changes in Registrant's Certifying Accountant
5:00pm
424B3
2tb7rx4vbjyu
12 Aug 22
Prospectus supplement
9:17am
8-K
EX-4.5
t8qjnkyul7o5yh6
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
8-K
n76d6scrk297g
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
424B5
bz2qutm8qsy s7t2
26 Jul 22
Prospectus supplement for primary offering
8:35am
424B5
u8vbavr
15 Feb 22
Prospectus supplement for primary offering
11:03am